AMSIGLAT Trademark

Trademark Overview

On Monday, June 17, 2019, a trademark application was filed for AMSIGLAT with the United States Patent and Trademark Office. The USPTO has given the AMSIGLAT trademark a serial number of 88476261. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by Pfizer Inc.. The AMSIGLAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological conditions, diseases and disorders
amsiglat

General Information

Serial Number88476261
Word MarkAMSIGLAT
Filing DateMonday, June 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological conditions, diseases and disorders
Translation of Words in MarkThe wording "AMSIGLAT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 23, 2022SOU EXTENSION 4 GRANTED
Monday, May 23, 2022SOU EXTENSION 4 FILED
Monday, May 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 22, 2021SOU EXTENSION 3 GRANTED
Monday, November 22, 2021SOU EXTENSION 3 FILED
Monday, November 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, May 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 11, 2021SOU EXTENSION 2 GRANTED
Tuesday, May 11, 2021SOU EXTENSION 2 FILED
Tuesday, May 11, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2020SOU EXTENSION 1 GRANTED
Thursday, November 19, 2020SOU EXTENSION 1 FILED
Thursday, November 19, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 14, 2020ASSIGNED TO LIE
Monday, February 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION WRITTEN
Thursday, September 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2019ASSIGNED TO EXAMINER
Thursday, June 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2019NEW APPLICATION ENTERED

Related Keywords

amsiglat diseases disorders conditions neurological preparations treatment pharmaceutical